Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics. Before the COVID-19 pandemic, the pregnancy test was the ...

The lateral flow assay market is poised for growth via increasing home-based self-testing kits, integration with smartphones for telehealth, and expansions in food safety and environmental monitoring.

As plan B measure are implemented across the UK, people are being urged to wear masks, work from home and take regular lateral flow tests. Lateral flow tests are for people who have no symptoms but ...

At-home test kits, also known as at-home medical tests or self-tests, are kits that you can purchase online, at supermarkets, or at your local pharmacy and use to detect or monitor certain diseases ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

The extent of Covid transmission and the shortage of test kits is becoming increasingly visible to more people as the omicron variant spreads. And people who have struggled to order lateral flow tests ...

Lateral flow tests have transformed global health care by enabling rapid disease detection and improving access to medical diagnostics. However, their widespread, single-use design is creating an ...

Lateral flow (LFD) tests are as likely to detect Omicron as other variants of coronavirus, according to the Health Security Agency (HSA). Dr Jenny Harries, HSA chief executive, said: “Our data shows ...

A London-based doctor is helping to clear up confusion around false positive Covid lateral flow tests - and has shared some advice on what to do if you’re unsure about your result. The rapid tests are ...

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...